Paul W. Wacnik, Ph.D., MBA

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Paul W. Wacnik, Ph.D., MBA, Research Director, Early Clinical Development, Pfizer, Inc. to its College of Fellows. Dr. Wacnik was nominated, reviewed, and elected by peers and members of the AIMBE College of Fellows for outstanding contributions to the development of medical devices and pharmaceutical solutions for chronic pain, movement disorders and respiratory diseases.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation, and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences… Continue reading.